Tuesday, March 19, 2013

Molecular Allergy Testing Gets Personal

There's a new player in personalized medicine: molecular allergy testing.
"We're not in the genomic testing business, so it may not be as obvious to the casual observer that we have an important place in personalized medicine," explains Robert Reinhardt, MD, chief medical officer of ImmunoDiagnostics of Thermo Fisher Scientific (formerly Phadia). "Individuals are unique in terms of their sensitization patterns. More sophisticated testing technology in this area will have a positive impact on patients through personalized education, therapies, guidance and outcomes."

Read more:
Molecular Allergy Testing Gets Personal
















Source: ADVANCED

Art and Science of Laboratory Medicine

Twitter: LaboratoryEQAS

No comments:

Post a Comment